New approaches to coronary heart disease: induction of neovascularisation by growth factors.

@article{Stegmann1999NewAT,
  title={New approaches to coronary heart disease: induction of neovascularisation by growth factors.},
  author={Thomas J. Stegmann},
  journal={BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy},
  year={1999},
  volume={11 5},
  pages={301-8}
}
Currently available approaches for treating human coronary heart disease aim to relieve symptoms and the risk of myocardial infarction by reducing myocardial oxygen demand (drugs), preventing further disease progression (drugs), restoring coronary blood flow either pharmacologically (thrombolysis) or mechanically (angioplasty), or bypassing the stenotic lesions and obstructed coronary artery segments (surgery). Direct gene therapy, as well as gene-derived therapy, especially by angiogenic… CONTINUE READING